MARC Record from marc_columbia

LEADER: 04987cam a22004334a 4500
001 5595550
005 20221121191217.0
008 041130s2005 flua 000 0 eng
010 $a 2004065568
016 7 $a101254923$2DNLM
020 $a0849318637
029 1 $aNLM$b101254923
035 $a(OCoLC)ocm57169963
035 $a(NNC)5595550
035 $a5595550
040 $aDLC$cDLC$dYDX$dBAKER$dNLM$dOrLoB-B
042 $apcc
050 00 $aRS431.A64$bA562 2005
060 00 $a2005 J-673
060 10 $aQV 269$bA6293 2005
082 00 $a616.99/4061$222
245 00 $aAnticancer agents from natural products /$cedited by Gordon M. Cragg, David G.I. Kingston, David J. Newman.
260 $aBoca Raton, Fla. :$bTaylor & Francis,$c2005.
300 $a577 pages :$billustrations (some color) ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gCh. 1.$tIntroduction /$rGordon M. Cragg, David G. I. Kingston and David J. Newman -- $gCh. 2.$tChamptothecin and its analogs /$rNicolas J. Rahier, Craig J. Thomas and Sidney M. Hecht -- $gCh. 3.$tThe discovery and development of the combretastatins /$rKevin G. Pinney, Christopher Jelinek, Klaus Edvardsen, David J. Chaplin and George R. Pettit -- $gCh. 4.$tHomoharringtonine and related compounds /$rHideji Itokawa, Xihong Wang and Kuo-Hsiung Lee -- $gCh. 5.$tPodophyllotoxins and analogs /$rKuo-Hsiung Lee and Zhiyan Xiao -- $gCh. 6.$tTaxol and its analogs /$rDavid G. I. Kingston -- $gCh. 7.$tThe vinca alkaloids /$rFrancoise Gueritte and Jacques Fahy -- $gCh. 8.$tThe bryostatins /$rDavid J. Newman -- $gCh. 9.$tThe isolation, characterization, and development of a novel class of potent antimitotic macrocyclic depsipeptides : the cryptophycins /$rRima S. Al-awar and Chuan Shih -- $gCh. 10.$tChemistry and biology of the discodermolides, potent mitotic spindle poisons /$rSarath P. Gunasekera and Amy E. Wright -- $gCh. 11.$tThe dolastatins : novel antitumor agents from Dolabella auricularia /$rErik Flahive and Jayaram Srirangam -- $gCh. 12.$tEcteinascidin 743 (ET-743; Yondelis), aplidin, and kahalaide F /$rRuben Henriquez, Glynn Faircloth and Carmen Cuevas -- $gCh. 13.$tDiscovery of E7389, a fully synthetic macrocyclic ketone analog of halichondrin B /$rMelvin J. Yu, Yoshito Kishi and Bruce A. Littlefield -- $gCh. 14.$tHTI-286, a synthetic analog of the antimitotic natural product hemiasterlin /$rRaymond J. Andersen and Michel Roberge -- $gCh. 15.$tThe actinomycins /$rAnthony B. Mauger and Helmut Lackner -- $gCh. 16.$tAnthracyclines /$rFederico Maria Arcamone -- $gCh. 17.$tAnsamitocins (maytansinoids) /$rTin-Wein Yu and Heinz G. Floss -- $gCh. 18.$tBenzoquinone ansamycins /$rKenneth M. Snader -- $gCh. 19.$tBleomycin group antitumor agents /$rSidney M. Hecht -- $gCh. 20.$tBiochemical and biological evaluation of (+)-CC-1065 analogs and conjugates with polyamides /$rRohtash Kumar and J. William Lown -- $gCh. 21.$tEpothilone, a myxobacterial metabolite with promising antitumor activity /$rGerhard Hofle and Hans Reichenbach -- $gCh. 22.$tEnediynes /$rPhilip R. Hamann, Janis Upeslacis and Donald B. Borders -- $gCh. 23.$tThe mitomycins /$rWilliam A. Remers -- $gCh. 24.$tStaurosporines and structurally related indolocarbazoles as antitumor agents /$rMichelle Prudhomme -- $gCh. 25.$tCombinatorial biosynthesis of anticancer natural products /$rMichael G. Thomas, Kathryn A. Bixby and Ben Shen -- $gCh. 26.$tDevelopments and future trends in anticancer natural products drug discovery /$rDavid J. Newman and Gordon M. Cragg.
520 1 $a"Anticancer Agents from Natural Products analyzes current clinically used anticancer agents that are natural products or clearly derived from natural product leads. Edited by leading scientists who have contributed enormously to natural product development and potential anticancer natural products, Anticancer Agents from Natural Products is a convenient summary of the current status of research and development of some of the most effective anticancer agents available today. It is an ideal foundation for scientists engaged in developing new and improved drugs based on natural sources."--BOOK JACKET.
650 0 $aAntineoplastic agents.$0http://id.loc.gov/authorities/subjects/sh85005714
650 0 $aPharmacognosy.$0http://id.loc.gov/authorities/subjects/sh85100596
650 0 $aNatural products.$0http://id.loc.gov/authorities/subjects/sh85090252
650 12 $aAntineoplastic Agents.$0https://id.nlm.nih.gov/mesh/D000970
650 22 $aBiological Factors.$0https://id.nlm.nih.gov/mesh/D001685
650 22 $aPharmacognosy.$0https://id.nlm.nih.gov/mesh/D010598
700 1 $aCragg, Gordon M. L.$0http://id.loc.gov/authorities/names/n80007728
700 1 $aKingston, David G. I.$0http://id.loc.gov/authorities/names/n2004017338
700 1 $aNewman, David J.$0http://id.loc.gov/authorities/names/nr92029782
852 00 $boff,hsl$hRS431.A64$iA562 2005